Clinical Trial Update: Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates BF-200 ALA (Ameluz) with BF-RhodoLED photodynamic therapy for adults with moderate to severe acne vulgaris. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)
• BF-RhodoLED

Snippet

Sponsor: Biofrontera Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: ACTIVE_NOT_RECRUITING